Invivyd Appoints Jeremy Gowler as Chief Operating and Commercial Officer, Promotes Pete Schmidt, M.D., to Chief Medical Officer

December 6, 2022

https://www.globenewswire.com/news-release/2022/12/06/2568776/0/en/Invivyd-Appoints-Jeremy-Gowler-as-Chief-Operating-and-Commercial-Officer-Promotes-Pete-Schmidt-M-D-to-Chief-Medical-Officer.html

WALTHAM, Mass., Dec. 06, 2022 (GLOBE NEWSWIRE) — Invivyd, Inc. (Nasdaq:IVVD), a clinical-stage biopharmaceutical company on a mission to protect humanity from serious viral respiratory diseases, today announced the appointment of Jeremy Gowler as chief operating and commercial officer, effective December 16, 2022, and the promotion of Pete Schmidt, M.D. to chief medical officer, effective immediately.

Read more at globenewswire.com

Related news for (IVVD)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.